Next Article in Journal
Increasing Phosphorus Uptake Efficiency by Phosphorus-Starved Microalgae for Municipal Wastewater Post-Treatment
Next Article in Special Issue
The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Previous Article in Journal
Decontamination Strategies Used for AFB Culture Significantly Reduce the Viability of Mycobacterium abscessus Complex in Sputum Samples from Patients with Cystic Fibrosis
Previous Article in Special Issue
Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
 
 
Review

Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections

Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium
*
Author to whom correspondence should be addressed.
Academic Editor: Valeria Cagno
Microorganisms 2021, 9(8), 1599; https://doi.org/10.3390/microorganisms9081599
Received: 22 June 2021 / Revised: 21 July 2021 / Accepted: 21 July 2021 / Published: 27 July 2021
(This article belongs to the Special Issue Antiviral Research)
Acute gastroenteritis caused by virus has a major impact on public health worldwide in terms of morbidity, mortality, and economic burden. The main culprits are rotaviruses, noroviruses, sapoviruses, astroviruses, and enteric adenoviruses. Currently, there are no antiviral drugs available for the prevention or treatment of viral gastroenteritis. Here, we describe the antivirals that were identified as having in vitro and/or in vivo activity against these viruses, originating from in silico design or library screening, natural sources or being repurposed drugs. We also highlight recent advances in model systems available for this (hard to cultivate) group of viruses, such as organoid technologies, and that will facilitate antiviral studies as well as fill some of current knowledge gaps that hamper the development of highly efficient therapies against gastroenteric viruses. View Full-Text
Keywords: norovirus; rotavirus; sapovirus; adenovirus; astrovirus; viral gastroenteritis; in vitro; in vivo; enteroids norovirus; rotavirus; sapovirus; adenovirus; astrovirus; viral gastroenteritis; in vitro; in vivo; enteroids
Show Figures

Figure 1

MDPI and ACS Style

Santos-Ferreira, N.; Van Dycke, J.; Neyts, J.; Rocha-Pereira, J. Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. Microorganisms 2021, 9, 1599. https://doi.org/10.3390/microorganisms9081599

AMA Style

Santos-Ferreira N, Van Dycke J, Neyts J, Rocha-Pereira J. Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. Microorganisms. 2021; 9(8):1599. https://doi.org/10.3390/microorganisms9081599

Chicago/Turabian Style

Santos-Ferreira, Nanci, Jana Van Dycke, Johan Neyts, and Joana Rocha-Pereira. 2021. "Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections" Microorganisms 9, no. 8: 1599. https://doi.org/10.3390/microorganisms9081599

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop